RevBio(R) Receives Approval from FDA to Start a Dental Clinical Trial for its Regenerative Bone Glue

RevBio, Inc., announced that it has received approval from the U.S. Food and Drug Administration to start a pilot clinical trial to examine the safety and efficacy of TETRANITE(R) , the company's ...

RevBio® Receives Approval from FDA to Start a Dental Clinical Trial for its Regenerative Bone Glue

RevBio, Inc., announced that it has received approval from the U.S. Food and Drug Administration to start a pilot clinical ...
American Association of Individual Investors

Which Is a Better Investment, Alphatec Holdings, Inc. or Omnicell, Inc. Stock?

Learn more about whether Alphatec Holdings, Inc. or Omnicell, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.